Fatal pneumonitis in children with metastatic rhabdomyosarcoma following whole lung radiotherapy and sequential epirubicin

Pediatric Blood and Cancer

Volumn 48, Issue 5, 2007, Pages 586-590

  Prestwich, R J ^a   Picton, S V ^b   Glaser, A ^b   Taylor, R E ^a  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Epirubicin; Pneumonitis; Radiotherapy; Rhabdomyosarcoma

Indexed keywords

AMPHOTERICIN; BUDESONIDE; CARBOPLATIN; DACTINOMYCIN; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; FLUCYTOSINE; IFOSFAMIDE; IMIPENEM; VINCRISTINE;

ARTICLE; BLOOD CULTURE; CANCER RADIOTHERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG METASTASIS; MALE; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SPUTUM CULTURE; STRIDOR; THORAX RADIOGRAPHY;

ANTIBIOTICS, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EPIRUBICIN; FATAL OUTCOME; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; NEOPLASM METASTASIS; RADIOTHERAPY; RHABDOMYOSARCOMA;

EID: 33947651293     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20660     Document Type: Article

References (36)

1. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study I. A Final Report. Cancer 1988;61: 209-220.
2. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993;71:1904-1922.
3. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995;13:610-630.
4. Mitchell C, Morris Jones P, Kelsey A, et al. The treatment of Wilms' tumour: Results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. Br J Cancer 2000;83:602-608.
5. Paulussen M, Ahrens S, Craft AW, et al. Ewing's tumours with primary lung metastases: Survival analysis of 114 (European Intergroup) cooperative Ewing's sarcoma studies patients. J Clin One 1998;16:3044-3052.
6. Shank B. The balancing act: Pneumonitis vs. relapse in cytoreductive regimens containing total body irradiation. Int J Radiat Oncol Biol Phys 1996;36:261-262.
7. Green DM, Finklestein JZ, Tefft ME, et al. Diffuse interstitial pneumonitis after pulmonary irradiation of metastatic Wilms' tumour. A report from the National Wilms' Tumour Study. Cancer 1989;63:450-453.
8. Trott KR, Herrmann T, Kasper M. Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys 2004;58:463-469.
9. Chen Y, Williams J, Ding I, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002;12:26-33.
10. Jeter MD, Janne PA, Brooks S, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002;53:394-400.
11. Seymour CB, Mothersill C, Alper T. High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1986;50:167-179.
12. Kitani H, Kosaka T, Fujihara T, et al. The 'recall effect' in radiotherapy: Is subeffective, reparable damage involved? Int J Radiat Oncol Biol Phys 1990;18:689-695.
13. Schweitzer VG, Juillard GJ, Bajada CL, et al. Radiation recall dermatitis and pneunonitis in a patient treated with paclitaxel. Cancer 1995;76:1069-1072.
14. Frascella E, Pritchard-Jones K, Modak S, et al. Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with Carboplatin, Epirubicin and Vincristine. Eur J Cancer 1996;5:821-825.
15. Brochstein JA, Kernan NA, Grohsen S, et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukaemia. N Engl J Med 1987;317:1618-1624.
16. Morgan TL, Falk PM, Kogut N, et al. A comparison of single dose and fractionated total body irradiation on the development of pneumonitis following bone marrow transplantation. Int J Radiat Biol Phys 1996;36:61-66.
17. Carruthers SA, Wallington MM. Total body irradiation and pneumonitis risk: A review of outcomes. Br J Cancer 2004;90: 2080-2084.
18. Socie G, Devergie A, Girinsky T, et al. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukaemia. The Group d'Etude des greffes de moelle osseuse (GEGMO). Int J Radiat Oncol Biol 1991;20: 397-404.
19. Lohr F, Wenz F, Schraube P, et al. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for haematological malignancies. Radiother Oncol 1998;48:45-51.
20. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988;6:1562-1568.
21. Wingard JR, Sostrin MB, Vriesendorp HM, et al. Transplantation 1998;46:61-65.
22. Sutton L, Kuentz M, Cordonnier C, et al. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukaemia in first complete remission: Factors predictive of transplant-related mortality and influence of total body irradiation. Bone Marrow Transplant 1993;12:583-589.
23. Ozsahin M, Schwartz LH, Pene F, et al. Is body weight a risk factor for interstitial pneumonitis after BMT? Bone marrow Transplant 1992;10:97.
24. Weiner RS, Bortin MM, Gale RP, et al. Interstital pneumonia after bone marrow transplantation. Assessment of risk factors. Ann Int Med 1986;104:168-175.
25. Green DM, Breslow J, Beckwith B, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumour: A report from the National Wilms' Tumour Study Group. J Clin Oncol 1998;16:237-245.
26. Burgers JM, van Glabbeke M, Busson A, et al. Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/ or prophylactic lung irradiation. Cancer 1988;61:1024-1031.
27. Phillips TL, Wharam MD, Margolis LW. Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 1975; 35:1678-1684.
28. Pearson D, Deakin DP, Hendry JH, et al. The interaction of actinomycin D and radiation. Int J Radiat Oncol Biol Phys 1978; 5:71-73.
29. Baeza MR, Barkley HT Jr, Fernandez CH. Total-lung irradiation in the treatment of pulmonary metastases. Radiology 1975;116:151-154.
30. Cohen IJ, Loven D, Schoenfeld T, et al. Dactinomycin potentiation of radiation pneumonitis: A forgotten interaction. Pediatr Hematol Oncol 1991;8:187-192.
31. Ma LD, Taylor GA, Wharam MD, et al. 'Recall' pneumonitis: Adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993;187:465-467.
32. Cassady JR, Richter MP, Piro AJ, et al. Radiation-adriamycin interactions: Preliminary clinical observations. Cancer 1975;36: 946-949.
33. McInerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin. Br J Radiol 1977;50:224-227.
34. Keane TJ, Van Dyk KW, Ryder WD. Interstitial pneumonitis following total body irradiation. Int J Radiat Oncol Biol Phys 1981;7:1365-1370.
35. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumour. Int J Radiat Oncol Biol Phys 2000;46:1239-1246.
36. Gross NJ. Radiation pneumonitis in mice. J Clin Invest 1980;66: 504-510.